SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending as the asset tests critical resistance at $75,000, with community sentiment split between short-term caution and aggressive accumulation driven by institutional ETF inflows. Investors are closely monitoring geopolitical developments alongside high short interest, fueling intense debate over whether this represents a breakout toward $80,000 or a liquidity trap for over-leveraged traders.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to the Greenland government's approval of the transfer of a majority interest in the Tanbreez rare earth deposit, fueling significant retail enthusiasm and short-squeeze speculation. The community is actively debating the company's newfound strategic control over this asset as a potential key to Western supply chain independence.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSTR is trending as investors react to the company's aggressive Bitcoin acquisition strategy and positive market sentiment driven by potential legislative progress for the sector. The community is actively debating the stock's long-term sustainability, focusing on the company's leverage and its role as a proxy for Bitcoin-related volatility.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is gaining significant community attention as investors anticipate upcoming data readouts and potential regulatory milestones, with many highlighting its perceived undervaluation compared to sector peers. The primary talking points focus on the potential for an explosive breakout driven by a tightening float and aggressive accumulation, while the community remains hyper-focused on the company's progress toward BLA submission and the strategic positioning of its clinical pipeline.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing significant market momentum following a high-profile endorsement from NVIDIA, which named the company as a key partner for its newly launched quantum computing AI models. Investors are actively discussing the stock's potential for a valuation catch-up compared to its sector peers, highlighting its established government contracts and diverse quantum sensing technology as competitive advantages.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing high volatility as investors weigh a strong earnings beat against softer-than-expected guidance and the departure of co-founder Reed Hastings. The community remains divided between those viewing the double-digit selloff as a prime buying opportunity and others expressing concern over slowing growth and an intensifying competitive landscape.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma shares are experiencing intense volatility and downward pressure as the market reacts to reports of Anthropic's emerging AI design capabilities, fueling investor fears about the long-term competitive moat for creative software. Despite strong underlying revenue growth and enterprise adoption, the community remains deeply divided, with some investors aggressively averaging down on what they view as a temporary valuation disconnect while others cite concerns over insider selling and a crowded field of AI-native alternatives.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is trending as the community debates the impact of the LitVM testnet launch, with many traders discussing its potential as a catalyst for future utility and price action. While some investors remain skeptical about persistent underperformance compared to other assets, others are viewing current price levels as an accumulation opportunity, pointing to long-term institutional interest and consistent network activity.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple's XRP is trending as the community debates the timing of the Clarity Act and speculates on its potential to integrate with major financial institutions. Discussion remains divided between long-term proponents highlighting its cross-border utility and skeptics focusing on price stagnation and concerns over supply dilution.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors await the upcoming quarterly earnings report and conference call, with community sentiment focused on the potential commercial ramp-up of its recently launched rare disease treatment, Yartemlea. Discussions highlight the significance of the company's solid balance sheet, its strategic partnership with Novo Nordisk, and anticipation regarding European market authorization, even as the stock price contends with volatility and ongoing short interest.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TMO Q1 Earnings Preview: Will Life Sciences Solutions Lead Results?

Thermo Fisher heads into Q1 earnings with Life Sciences Solutions growth in focus, as bioproduction strength and new innovations may drive results.

Short Interest in OnKure Therapeutics, Inc. (NASDAQ:OKUR) Increases By 1,958.6%

OnKure Therapeutics, Inc. (NASDAQ:OKUR - Get Free Report) saw a large increase in short interest in March. As of March 31st, there was short interest totaling 163,904 shares, an increase of 1,958.6% from the March 15th total of 7,962 shares. Based on an average daily volume of 786,389 shares, the...

OnKure Therapeutics, Inc. (NASDAQ:OKUR) Short Interest Down 85.2% in March

OnKure Therapeutics, Inc. (NASDAQ:OKUR - Get Free Report) was the target of a significant decline in short interest in March. As of March 13th, there was short interest totaling 7,962 shares, a...

HC Wainwright Has Positive Forecast for OKUR Q1 Earnings

OnKure Therapeutics, Inc. (NASDAQ:OKUR - Free Report) - Stock analysts at HC Wainwright upped their Q1 2026 earnings per share (EPS) estimates for OnKure Therapeutics in a research note issued to...

OnKure Therapeutics (NASDAQ:OKUR) Price Target Lowered to $27.00 at HC Wainwright

HC Wainwright dropped their price objective on OnKure Therapeutics from $34.00 to $27.00 and set a "buy" rating on the stock in a research report on Monday...

OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer. It is headquartered in Boulder, CO.

OKUR
Onkure Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest OKUR News

OKUROnkure Therapeutics Inc